In pancreatic ductal adenocarcinoma (PDAC), co-occurring TP53 and KRAS mutations drive tumor growth and metastasis through interaction with CREB-1 (cAMP responsive element binding protein 1) [55]. Here, KRAS is linked to neoplasm.